HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
IONQ
IonQ, Inc.
There isn't enough reported data to score IONQ yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
IONQ Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Weak | |
| Unavailable |
IONQ's revenue is currently healthy, and its profitability is stable, but its cash flow is weak. There isn't enough data to rate its balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
IONQ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 33x | $30.86 | โ |
| Cheap | 86x | $80.61 | +161% |
| Fair | 126x | $119 | +285% |
| Expensive | 147x | $138 | +349% |
Historical ranges are pointers, not guarantees.
IONQ's PE is 33x, but its earnings don't support one, so it isn't a reliable read right now.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
IONQ Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect IONQ's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
IONQ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.94 | +$6.31 |
| Q2 2026 | -$3.99 | -$1.96 |
| Q1 2026 | $0.39 | +$1.90 |
| Q4 2025 | -$1.82 | -$0.26 |
| Q3 2025 | -$5.37 | -$4.56 |
| Q2 2025 | -$2.03 | -$1.24 |
| Q1 2025 | -$1.51 | -$0.68 |
| Q4 2024 | -$1.56 | -$0.78 |
IONQ has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS's revenue has grown year over year every quarter since late 2021: $890M last quarter, up 49% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over IONQ on profitability, with a higher operating margin.
IONQ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $173.8M | +336% |
| Q2 2026 | $80.1M | +287% |
| Q1 2026 | $64.7M | +755% |
| Q4 2025 | $61.9M | +429% |
| Q3 2025 | $39.9M | +222% |
| Q2 2025 | $20.7M | +82% |
| Q1 2025 | $7.6M | -0.2% |
| Q4 2024 | $11.7M | +92% |
IONQ's revenue is recovering but still below its 2022 peak: $174M last quarter, up 336% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -249% | +174 points |
| Q2 2026 | -421% | +355 points |
| Q1 2026 | -420% | +580 points |
| Q4 2025 | -369% | +292 points |
| Q3 2025 | -423% | +5.1 points |
| Q2 2025 | -776% | -346 points |
| Q1 2025 | -1000% | -303 points |
| Q4 2024 | -662% | +230 points |
IONQ's operating margin was โ249% last quarter, up 174 points from the same quarter a year ago, near the top of its range since 2021.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over IONQ on cash generation, producing positive trailing cash flow while its opponent burns cash.
IONQ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$331.9M | -$204.7M |
| Q2 2026 | -$114M | -$60.2M |
| Q1 2026 | -$159.4M | -$124.1M |
| Q4 2025 | -$83.3M | -$40.3M |
| Q3 2025 | -$127.2M | -$104.2M |
| Q2 2025 | -$53.8M | -$19.7M |
| Q1 2025 | -$35.3M | -$11.7M |
| Q4 2024 | -$43M | -$9.2M |
IONQ has burned cash in almost every quarter: โ$689M over the past year, against โ$259M the year before.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
IONQ Net Leverage
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
IONQ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.7 | Neutral |
| Stochastic | 22.3 | Neutral |
IONQ's weekly RSI is 41 (neutral) and its Stochastic is 22 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | โ |
HIMS has no meaningful PE right now: it lost money over the past year.
IONQ PE vs Technology Sector
| Metric | IONQ | Sector median | Relative |
|---|---|---|---|
| PE | 33x | 28x | 18% above |
IONQ is trading at 33x earnings, a 18% premium to the Technology sector's median of 28x, though its earnings don't support one.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
IONQ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $35.7 | 13% below |
| 20 week MA | $38.6 | 20% below |
| 50 week MA | $42.4 | 27% below |
| 100 week MA | $42.2 | 27% below |
| 200 week MA | $26.8 | 15% above |
IONQ has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to โ56% in 2021. It's down 42% so far in 2026.
IONQ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $11.0 | $17.9 | +62% |
| 2022 | $17.9 | $3.30 | -82% |
| 2023 | $3.30 | $12.4 | +275% |
| 2024 | $12.4 | $45.5 | +267% |
| 2025 | $45.5 | $46.0 | +1.1% |
| 2026 YTD | $46.0 | $30.9 | -33% |
IONQ has the edge over HIMS on returns for 2026, with the stronger performance.